CIOs Join Forces to Battle Cancer

A coalition of healthcare IT chiefs are on a mission to put cancer out of business.

1 2 Page 2
Page 2 of 2

That adds a dimension to the CIO role. "I have to deliver an awful lot of basic services like every other CIO--networks, storage, file services, security. But I have this really exciting additional mission to take into account," he says. "On one side, it's the classic CIO blocking and tackling. On the other, it's how do we interface with the scientific community to further our mission. There's opportunity to do better on both fronts."

Very Big Data

Jack London, director of the informatics shared resource at the Kimmel Cancer Center, says he's been in medical informatics since before it was called informatics. A version of the first mainframe he worked with could be a museum piece. He's seen technology tools evolve to keep up with the demands of cancer research and treatment. For the last few years, he has focused on personalized cancer medicine.

"If you go back to the 1950s until very recently, the way we treat cancer is to give people a set of toxic drugs that kill the rapidly growing cells, and you adjust the dose so you don't kill the patient at the same time. It's the brute-force approach," London says. "But cancer is a genetic disease." From an IT perspective, that means not only analyzing very large sets of genomic information, but also managing specimen banks and their associated clinical data and correlating that with the latest research. "You get [up] to terabytes of data in a very short time," London says.

Then you have to figure out what to do with those terabytes. The goal is clinically actionable results. "You have to get to point that you can put it in an electronic health record and communicate that to the clinician who is treating a patient today," London says. "That's what everyone is working very hard on."

At Memorial Sloan Kettering, physicians have been archiving samples of patients' cancer cells, along with their clinical histories, for 30 years. Skarulis oversees one of the largest single-organization data warehouses for patient care and clinical research in the country.

Sloan Kettering's secure, Web-based system contains more than a million cancer patient records and is the basis for research into the complex mechanisms that cause cancers to form or progress. Such investigations have resulted in more effective therapies and diagnostic tools for some lung, colorectal and skin cancers.

Next-generation sequencing will take that to the next level. It "can spew out data at a rate that's incomprehensible, but that data has to be stored, processed and made available to doctors," says Skarulis, whose team rolled out a system in May to do just that.

"We've been meeting with many, many people from the institution--experts in everything from computational biology to sequencing itself--working together to pull this off," she says. "I couldn't be alive at a more exciting time in cancer research, and we're helping to get that to the bedside."

Both the technology and the science are advancing rapidly. "The explosion in technology is enabling us to examine things we couldn't look at before," Skarulis says. "One is enabling the other."

"Data," says Nadaf, "is driving change."

A Team Science

That explosion of data is also fostering closer relationships among CIOs in the research and clinical area.

"In the last 20 years," says Kibbe of NCI, "it's become clearer and clearer that cancer research is a team science. My job is very much the facilitator of that."

The U.S. government paved the way for increased collaboration with the Cancer Biomedical Informatics Grid (CaBIG) in 2004, a program to develop an open-source, open-access information network for cancer research.

"Before that, everyone was working in silos," says London of the Kimmel Cancer Center, "and not only working in silos, but competing for grant dollars." As a result, groups at various institutions might have been getting funding to work on similar or duplicative projects.

"They knew they needed to get them to share their data, and they seized upon the IT infrastructure as a way to do that," London says.

Ultimately, the CaBIG program was retired, but not before "it got us all working together," he says.

London and other biomedical informatics leaders in the NCI system are cooperating in various areas to better support the scientists and clinicians at their individual institutions. Last year, Kibbe and Nadaf launched Cancer Informatics for Cancer Centers, a national nonprofit that holds in-person meetings and conference calls on topics such as intellectual capital and cloud computing. Much like the group of nonprofit cancer organization CIOs, each IT leader brings his or her own areas of expertise to the group. London, for example, shares his approach to delivering clinically actionable results. Kibbe would like to see the alliance go worldwide.

"If we want to dive deeper into solutions to our problems, we can't do it alone. That doesn't benefit the patient at all," Nadaf says. "The more we collaborate, the more of a difference we make."

The Mission Continues

Not every day in the cancer battle is a good day. Loss is a fact of life for CIOs in the field.

"One of the things I've learned from St. Jude patients is that while survival is incredibly important, what's equally important is to thrive with every day that we're given," says Machen on the morning he was to attend the memorial service for an 8-year-old patient who had become a dear friend.

"One of the most beautiful things in the world was to see how much she cared and loved others at a time in her life where she could have been self-centered. It's tough, but a day like today is an everlasting reminder of the awesome nature of our mission."

That patient focus is something Nadaf of UCSF picked up when he was starting out. He worked in the lab of internationally renowned lung cancer expert Dr. David Carbone. "We had the very first gene therapy protocol in the country for advanced lung cancer," he recalls. "I was a young twentysomething and very excited." Nadaf would accompany Carbone on grand rounds and tumor boards weekly, and he saw patients suddenly slip away.

"I saw how fast patients died, and it was troubling to me," says Nadaf. "Today I know the difference can be in the data. There's power in the data. And my job is to continue to bring out as much as I can from the data to help each patient."

Given the prevalence of cancer, CIOs don't have to go far to see the impact of their work. "Everyone on my staff knows someone who's been affected. Some have fought cancer themselves," says Skarulis of Sloan Kettering. "We're not doing something for some remote benefit, something that might do some good in the future. We see on a day-to-day basis how what we do effects people's lives." That creates a sense of urgency in IT. "Every day that we don't know something is a day we haven't helped someone," she says.

But that pressure to do the best possible work is self-imposed and ultimately a positive force, says Skarulis, pointing to the fact that Sloan Kettering's employee engagement numbers are "off the charts."

"Everyone who's engaged in this mission is enthused and infused with the knowledge that they're moving cancer care and treatment forward," says Kibbe.

Mission--it's a word you hear a lot when you're talking to CIOs in the cancer field. And, yes, you'd probably hear a commercial CIO throw the word around, too, and mean it. But the mission of IT leaders at these nonprofits might sound odd to their for-profit counterparts.

"Our goal is to end cancer," says Ferro. "If we're out of business because we've solved the cancer problem, we'll find other jobs. We'd love to put ourselves out of business."

Cancer Research May Be More Affordable in the Cloud

There's too much data for small labs to handle affordably. The answer may be putting petabytes in a central repository so more researchers have access.

as the volume of data generated by genomics-related cancer research technologies has grown, the storage, transmission and analysis of data has become too costly for individual labs and most small-to-midsize research organizations to handle. So the National Cancer Institute (NCI) is looking to the cloud to make access to large, valuable data collections and advanced computational capacity available to as many doctors and scientists as possible.

NCI says that, during a two-year pilot program, it will award up to $20 million to three cloud providers that can meet their technical and cost criteria. The ultimate goal is to build one or more clouds filled with data from the NCI's Cancer Genome Atlas and allow researchers to tap into it using data mining and analysis tools.

The Cancer Genome Atlas's current petabyte of data will grow, by the end of this year, to 2.5 petabytes of genomic information from 11,000 patients. Building the infrastructure to store all that would cost a research institution at least $2 million, according to Warren Kibbe, NCI's CIO and director of its Center for Biomedical Informatics and Information Technology, making the task cost-prohibitive for many small colleges and other research institutions. By putting the data in the cloud, possibly using an on-demand pricing model, NCI may be able to expand the number of researchers working with the data, thereby speeding up genomics-based cancer research.

IBM's Watson Trained to Suggest the Best Cancer Treatment

Researchers, physicians and analysts at Memorial Sloan Kettering Cancer Center have been training Watson, IBM's supercomputer, for more than a year to turn it into a decision-support tool that helps medical professionals choose the best treatment plans for individual cancer patients.

The goal is to improve quality of care for cancer patients no matter where they are located by giving their doctors access to the same up-to-date research as doctors at the nation's leading cancer centers. "Here at Sloan Kettering, our people are all sub-specialists. If you treat lung cancer, that's all you treat and you become very good at it," says Patricia Skarulis, the institute's CIO. "If you are doctor in a smaller community, you might see lung cancer one day, then breast cancer the next week, then a thoracic patient after that. It's hard to stay up-to-date on everything you need to know. We want to export our knowledge to the rest of the world through technology."

Ultimately, Watson will import data about a patient--pathology and radiology reports, vital statistics, initial consultation, and any other pertinent information about the patient's health--correlate that with the current research and protocols, and come back with suggestions. Watson might tell the doctor that there's a 60 percent chance that treatment A is best for the patient and a 50 percent chance that treatment B is best. The supercomputer might also suggest additional tests that will enable it to offer better probabilities.

"Changes in technology such as cognitive computing are increasing our ability to go in and look at things we haven't been able to look at in the past," Skarulis says. "We're on the cusp of some of the most exciting changes in medicine."

 

Copyright © 2014 IDG Communications, Inc.

1 2 Page 2
Page 2 of 2
Get the best of CIO ... delivered. Sign up for our FREE email newsletters!